| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 2 | |
| #2 | Taiwan | 2 | |
| #3 | Australia | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | Jordan | 1 | |
| #8 | Mexico | 1 | |
| #9 | United States | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kwan Min-Fun Rudolf | 8 |
| #2 | Kramer E Douglas | 7 |
| #3 | Glue Paul William | 7 |
| #4 | Jackson Christopher Glyn Charles Alexander | 6 |
| #5 | Fetterly Geralk J | 5 |
| #6 | Smolinski Michael P | 4 |
| #7 | Hung Cheung-Tak | 4 |
| #8 | Lau Johnson Yiu-Nam | 4 |
| #9 | Kwan Min Fun Rudolf | 3 |
| #10 | Hung Cheung Tak | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019200290A1 | Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of angiosarcoma | |
| JO3737B1 | THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER |